ATE216779T1 - Immunoassays für anti-hcv-antikörper unter verwendung von antigenen mit konformationsepitopen - Google Patents

Immunoassays für anti-hcv-antikörper unter verwendung von antigenen mit konformationsepitopen

Info

Publication number
ATE216779T1
ATE216779T1 AT93916942T AT93916942T ATE216779T1 AT E216779 T1 ATE216779 T1 AT E216779T1 AT 93916942 T AT93916942 T AT 93916942T AT 93916942 T AT93916942 T AT 93916942T AT E216779 T1 ATE216779 T1 AT E216779T1
Authority
AT
Austria
Prior art keywords
antigens
conformational epitopes
hcv
immunoassays
hcv antibodies
Prior art date
Application number
AT93916942T
Other languages
English (en)
Inventor
David Y Chien
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25429280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216779(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of ATE216779T1 publication Critical patent/ATE216779T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
AT93916942T 1992-07-07 1993-07-02 Immunoassays für anti-hcv-antikörper unter verwendung von antigenen mit konformationsepitopen ATE216779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91075992A 1992-07-07 1992-07-07
PCT/US1993/006309 WO1994001778A1 (en) 1992-07-07 1993-07-02 Immunoassays for anti-hcv antibodies using antigens with conformational epitopes

Publications (1)

Publication Number Publication Date
ATE216779T1 true ATE216779T1 (de) 2002-05-15

Family

ID=25429280

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93916942T ATE216779T1 (de) 1992-07-07 1993-07-02 Immunoassays für anti-hcv-antikörper unter verwendung von antigenen mit konformationsepitopen

Country Status (19)

Country Link
US (1) US20020150883A1 (de)
EP (1) EP0649537B2 (de)
JP (2) JP3490085B2 (de)
AT (1) ATE216779T1 (de)
AU (1) AU685059B2 (de)
CA (1) CA2139645C (de)
CZ (1) CZ291951B6 (de)
DE (1) DE69331845T3 (de)
DK (1) DK0649537T4 (de)
ES (1) ES2171414T5 (de)
FI (1) FI110546B (de)
HU (1) HUT70473A (de)
NO (1) NO321185B1 (de)
PL (1) PL174686B1 (de)
PT (1) PT649537E (de)
RU (1) RU2126158C1 (de)
SK (1) SK284556B6 (de)
UA (1) UA39944C2 (de)
WO (1) WO1994001778A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
US5882852A (en) * 1993-06-29 1999-03-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Hepatitic C virus (HCV) core gene nucleotide sequences and related methods of detecting major and minor genotypes of HCV isolates
US7070790B1 (en) 1993-06-29 2006-07-04 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 and core genes of isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
BR9506059A (pt) * 1994-07-29 1997-10-28 Innogenetics Nv Proteinas envelopes purificadas de virus c para uso de diagnóstico e terapêutico
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5707385A (en) * 1994-11-16 1998-01-13 Advanced Cardiovascular Systems, Inc. Drug loaded elastic membrane and method for delivery
EP0836708A1 (de) * 1995-06-07 1998-04-22 Abbott Laboratories Nachwisverfahren für antikörper gegen das zweite hüllprotein des hepatitis c virus
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
WO2000026673A1 (en) * 1998-11-03 2000-05-11 Abbott Laboratories Methods of detecting chronic infection caused by hcv
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
EP1295126B1 (de) * 1999-07-28 2007-01-24 Novartis Vaccines and Diagnostics, Inc. Verfahren zum nachweis von hepatitis c antigenen
DK1354204T4 (da) * 2000-06-15 2010-06-14 Novartis Vaccines & Diagnostic HCV-antigen/antistof-kombinationssay
EP1829891B1 (de) 2000-06-15 2012-12-26 Novartis Vaccines and Diagnostics, Inc. Immuntests für Anti-HCV-Antikörper
RU2194993C2 (ru) * 2000-12-28 2002-12-20 Научно-исследовательский институт вирусологии им.Д.И.Ивановского РАМН Способы ускоренной диагностики гепатита с, основанные на обнаружении гемагглютининов вируса гепатита с и антител к ним в рга и ртга в крови людей
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
RU2192011C1 (ru) * 2001-11-26 2002-10-27 Иткес Александр Веньяминович Набор "микровирус" для обнаружения днк вич, интегрированной в хромосомы инфицированных клеток
ATE410693T1 (de) 2002-09-09 2008-10-15 Novartis Vaccines & Diagnostic Hcv-test
CN101124315A (zh) * 2003-01-17 2008-02-13 伊势龙医学股份有限公司 利用凝集素亲和性血液透析去除血液中病毒的方法
WO2004071414A2 (en) * 2003-02-05 2004-08-26 Genzyme Corporation Therapeutic anti-hcv (al9) compounds
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
ES2377978T3 (es) 2004-08-27 2012-04-03 Novartis Vaccines And Diagnostics, Inc. Mutantes de proteínas no estructurales de VHC y usos de los mismos
WO2008024518A2 (en) 2006-08-25 2008-02-28 Novartis Ag Hcv fusion polypeptides
EP3067048B1 (de) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Zusammensetzungen zur induzierung von immunreaktionen
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
JP2016512241A (ja) 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 改良された抗体検出のためのｈｃｖｎｓ３組換え抗原およびこの突然変異体
CN113549148B (zh) 2013-03-14 2025-11-21 雅培制药有限公司 Hcv核心脂质结合结构域单克隆抗体
BR112015023239A8 (pt) 2013-03-14 2018-04-17 Abbott Lab ensaio de combinação de anticorpo-antígeno de hcv e métodos e composições para uso do mesmo
WO2016160046A1 (en) 2015-03-27 2016-10-06 Ortho-Clinical Diagnostics, Inc. Hcv ns4a/modified ns3 polypeptides and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
NZ227011A (en) 1987-11-18 1992-03-26 Chiron Corp Non-a, non-b-hepatitis (hepatitis c) antigens, proteins, nucleotide sequences, vaccines and kits
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
BE1005485A5 (fr) * 1989-12-18 1993-08-10 Wellcome Found Agent viral.
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
HU217025B (hu) * 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
CA2079912C (en) * 1990-04-06 2000-07-11 Gregory Reyes Hepatitis c virus epitopes
FI913068L (fi) * 1990-06-25 1991-12-26 Univ Osaka Res Found Non-a-, non-b-hepatitisviruspartiklar.
KR0181517B1 (ko) * 1990-07-09 1999-04-01 나까하라 노부유끼 비-에이 비-비형 간염-특이 항원 및 간염 진단에서 그의 용도
EP0842947B2 (de) * 1990-11-08 2009-03-18 Novartis Vaccines and Diagnostics, Inc. Asialoglykoproteine des Hepatitis C Virus
IT1249684B (it) * 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
US5587285A (en) * 1992-01-31 1996-12-24 University Of Texas System Generation serological assay for monitoring HIV exposure
EP0627000B1 (de) * 1992-01-31 2003-10-29 Abbott Laboratories Expressionssystem in säugetieren für hcv-proteine

Also Published As

Publication number Publication date
NO950006L (no) 1995-02-24
PL174686B1 (pl) 1998-08-31
CA2139645A1 (en) 1994-01-20
WO1994001778A1 (en) 1994-01-20
JP2003329687A (ja) 2003-11-19
SK495A3 (en) 1995-07-11
FI950002A0 (fi) 1995-01-02
DK0649537T3 (da) 2002-06-17
CZ695A3 (en) 1996-03-13
JP3490085B2 (ja) 2004-01-26
DE69331845T2 (de) 2002-08-14
PL307178A1 (en) 1995-05-02
JPH07509060A (ja) 1995-10-05
FI950002L (fi) 1995-02-27
FI110546B (fi) 2003-02-14
HUT70473A (en) 1995-10-30
EP0649537B2 (de) 2006-02-22
DK0649537T4 (da) 2006-04-10
ES2171414T5 (es) 2006-09-01
RU2126158C1 (ru) 1999-02-10
NO950006D0 (no) 1995-01-02
DE69331845D1 (de) 2002-06-06
CZ291951B6 (cs) 2003-06-18
UA39944C2 (uk) 2001-07-16
DE69331845T3 (de) 2006-10-05
PT649537E (pt) 2002-09-30
ES2171414T3 (es) 2002-09-16
NO321185B1 (no) 2006-04-03
RU94046284A (ru) 1997-02-27
EP0649537B1 (de) 2002-04-24
AU685059B2 (en) 1998-01-15
SK284556B6 (sk) 2005-06-02
US20020150883A1 (en) 2002-10-17
CA2139645C (en) 2003-02-11
AU4662993A (en) 1994-01-31
HU9500008D0 (en) 1995-03-28
EP0649537A1 (de) 1995-04-26

Similar Documents

Publication Publication Date Title
ATE216779T1 (de) Immunoassays für anti-hcv-antikörper unter verwendung von antigenen mit konformationsepitopen
EP0351248A3 (en) Detection of an antibody and antigen in an immunoassay
ATE331952T1 (de) Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
ATE67313T1 (de) Nachweis von menschlichem cytomegalovirusspezifischem igm.
CA2004478A1 (en) Monoclonal antibodies to feline-t-lymphotropic lentivirus
ATE172542T1 (de) Vergrössertes western blot format und ein immunotestverfahren für die bestimmung von viralen antikörpern
ATE210680T1 (de) Antikörper gegen hypophysäre adenylatzyklase aktivierende peptid-pacap, hybridome und bestimmung von pacap
CA2111325A1 (en) Detection of mammalian immunodeficiency viruses
ATE51709T1 (de) Antigen im zusammenhang mit der fruehzeitigen feststellung von schwangerschaft bei saeugern.
CA2113383A1 (en) Immunometric determination of an antigen or hapten
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
KR930008155A (ko) 씨형 간염 바이러스(hcv)에 대한 모노클로날 항체
KR890014729A (ko) 비-a, 비-b형 간염 감염된 간에 대한 모노클로날 항체의 제조방법
EP0242589A3 (de) Nachweis von Haptenen in Immunotestverfahren
KR950700423A (ko) 씨(c)형 간염 비루스에 대한 단일클론 항체 및 항-유전자형 항체(monoclonal antibodies and anti-idiotypic antibodies to hepatitis c virus)
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
FI904304A0 (fi) Foerfarande foer paovisande av analyter.
EP0304329A3 (de) Monoklonale Antikörper und Hybridome und sensibilisierende Zellen für die Untersuchung von HBs-Antigenen
Karetnyĭ et al. Study of human and simian hepatitis A virus isolated by an immunoenzyme method using polyclonal and monoclonal antibodies
Rivanera et al. Evaluation of indeterminate sera for hepatitis C virus by assays using synthetic peptides
KR900018368A (ko) 하나 또는 그 이상의 관련 비루스의 항원에 대해 지시된 항체 검출용 진단 시험물
Huebschle et al. ELISA for the detection of Teschen virus antibodies in pig sera.
KR880000793A (ko) 샌드위치식 면역분석용 시약 복합물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0649537

Country of ref document: EP